Alkermes Plc (ALKS)
30.10
-0.63
(-2.05%)
USD |
NASDAQ |
Feb 27, 16:00
30.12
+0.02
(+0.05%)
After-Hours: 20:00
Alkermes Research and Development Expense (TTM) : 318.36M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Avadel Pharmaceuticals Plc | 39.89M |
| Krystal Biotech, Inc. | 55.08M |
| Assertio Holdings, Inc. | 2.49M |
| Amarin Corp. Plc | 17.52M |
| Amicus Therapeutics, Inc. | 135.84M |